|Videos|December 20, 2019

Management of HER2 Expression in Breast Cancer

Ian E. Krop, MD, PhD, provides insight on HER2 expression in breast cancer, treatment for blocking HER2, and the management of newly diagnosed HER2+ metastatic breast cancer with T-DM1.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!

Related Content

Why Should Patients With Breast Cancer Prioritize Wellness?

ByDr. Sheldon Marc Feldman

October 28th 2025

Community of Support Available for Patients With Cancer

ByAlyson B. Moadel-Robblee

October 28th 2025

What Patients With Cancer Should Know About Radiation Side Effects

ByAlexa M. Lantz

October 27th 2025

How Does FDA-Approved Blenrep Treat Multiple Myeloma?

ByDr. Surbhi Sidana

October 24th 2025

Insights on Fertility and Survivorship in Hairy Cell Leukemia

ByDr. Alessandro Gozzetti

October 24th 2025

Management of HER2 Expression in Breast Cancer

Newsletter

Related Content

Why Should Patients With Breast Cancer Prioritize Wellness?

Community of Support Available for Patients With Cancer

What Patients With Cancer Should Know About Radiation Side Effects

How Does FDA-Approved Blenrep Treat Multiple Myeloma?

Insights on Fertility and Survivorship in Hairy Cell Leukemia

Trending on CURE

What Patients With Cancer Should Know About Radiation Side Effects

Moving Forward After Follicular Lymphoma With a New Companion

What Dermatological Side Effects Can Patients With Breast Cancer Expect?

When the Fear of Cancer Creeps Back

Community of Support Available for Patients With Cancer